Clinical trial
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II…
NCT00262743 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00262743 |
|---|---|
| Title | Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia |
| Official title | A Phase I/II Study of Daily Oral Polyphenon E in Asymptomatic, Rai Stage 0-II Patients With Chronic Lymphocytic Leukemia |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological |
| Interventions | Polyphenon E |
| Enrollment | 73 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | Aug 1, 2012 |
| First posted | Dec 7, 2005 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: